Bionano Genomics (BNGO) Total Debt (2017 - 2023)

Bionano Genomics' Total Debt history runs 7 years deep, the most recent figure standing at $10.0 million for Q3 2023.

• In Q3 2023, Total Debt rose 7.49% year-over-year to $10.0 million; the TTM figure through Sep 2023 stood at $10.0 million (up 7.49% YoY), while the FY2022 annual figure was $9.4 million, changed N/A from the prior year.
• Total Debt came in at $10.0 million for Q3 2023 at Bionano Genomics, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $20.1 million in Q4 2019 to a low of $9.2 million in Q2 2022.
• A 5-year average of $14.3 million and a median of $15.7 million in 2020 frame the typical range for Total Debt.
• Across the five-year window, Total Debt surged 122.44% in 2019 and slipped 19.09% in 2020, its largest moves.
• Bionano Genomics' Total Debt stood at $20.1 million in 2019, then slipped by 18.72% to $16.3 million in 2020, then fell by 8.94% to $14.9 million in 2021, then sank by 36.89% to $9.4 million in 2022, then increased by 6.59% to $10.0 million in 2023.
• According to Business Quant data, Total Debt over the past three periods registered $10.0 million, $10.0 million, and $9.5 million for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison